Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...
Nature5y
INTERLEUKIN-6 LEVELS IN NEONATAL SEPSIS
Interleukin-6 (IL-6) is a central mediator of ... For sepsis, plasma IL-6 >0.235ng/ml had a sensitivity of 33%, specificity of 89%, +ve predictive value 60%, -ve predictive value 73%, figures ...
PharmiWeb7d
Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...